抗体将会捆住血型糖蛋白并使血细胞凝固。
The antibodies will bind to the glycophorin and cause the blood cells to coagulate.
血型糖蛋白A（GPA）基因突变频率在作为生物剂量计及癌的风险预测方面最大的缺陷在于个体差异大。
The prominent disadvantage of using GPA mutation frequency as biodosimeter and cancer risk predictor is the significant individual differences.
血型糖蛋白A（GPA）基因突变频率在作为生物剂量计及癌的风险预测方面最大的缺陷在于个体差异大。
The prominent disadvantage of using GPA mutation frequency as biodosimeter and cancer risk predictor is the significant individual differences.
应用推荐